Phenotyping transgenic animals-An integrated readout of pathophysiology by combining proteomics and metabolomics with cardiovascular imaging

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 4, 2010, Pages 571-573

  Puntmann, Valentina O ^a   Mayr, Manuel ^b  

^a Department of Experimental Medicine   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE; CREATINE KINASE; CREATINE PHOSPHATE; ENOLASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; EDITORIAL; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; HUMAN; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; PROTEOMICS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUPPLEMENTATION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARDIOVASCULAR DISEASES; DIAGNOSTIC IMAGING; FATTY ACIDS, NONESTERIFIED; GENETIC TECHNIQUES; GLUCOSE; METABOLOMICS; MICE; MICE, TRANSGENIC; OXIDATIVE STRESS; OXYGEN; PHENOTYPE; PROTEOMICS;

ANIMALIA;

EID: 77649275674     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.12.001     Document Type: Editorial

References (18)

1. Taegtmeyer H., Golfman L., Sharma S., Razeghi P., and van Arsdall M. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann. N. Y. Acad Sci. 1015 (2004) 202-213
2. Harmancey R., Wilson C.R., and Taegtmeyer H. Adaptation and maladaptation of the heart in obesity. Hypertension 52 (2008) 181-187
3. Neubauer S. The failing heart-an engine out of fuel. N. Engl. J. Med. 356 (2007) 1140-1151
4. Ingwall J.S., and Weiss R.G. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ. Res. 95 (2004) 135-145
5. Horn M., Remkes H., Dienesch C., Hu K., Ertl G., and Neubauer S. Chronic high-dose creatine feeding does not attenuate left ventricular remodelling in rat hearts post-myocardial infarction. Cardiovasc. Res. 43 (1999) 117-124
6. Ten Hove M., Makinen K., Sebag-Montefiore L., Hunyor I., Fischer A., Wallis J., et al. Creatine uptake in mouse hearts with genetically altered creatine levels. J. Mol. Cell. Cardiol. 45 (2008) 453-459
7. Phillips D., ten M.H., Schneider J.E., Wu C.O., Sebag-Montefiore L., Aponte A.M., et al. Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity. J. Mol. Cell. Cardiol. (2009 Nov 11)
8. Wallis J., Lygate C.A., Fischer A., ten Hove M., Schneider J.E., Sebag-Montefiore L., et al. Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice. Circulation 112 (2005) 3131-3139
9. Neubauer S. Cardiac physiology investigated by new methods of imaging. Clin. Med. 7 (2007) 189-191
10. Nakae I., Mitsunami K., Matsuo S., Matsumoto T., Morikawa S., Inubushi T., et al. Assessment of myocardial creatine concentration in dysfunctional human heart by proton magnetic resonance spectroscopy. Magn. Reson. Med. Sci. 3 (2004) 19-25
11. Mayr M., Chung Y.L., Mayr U., McGregor E., Troy H., Baier G., et al. Loss of PKC-delta alters cardiac metabolism. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H937-H945
12. Mayr M., Yusuf S., Weir G., Chung Y.L., Mayr U., Yin X., et al. Combined metabolomic and proteomic analysis of human atrial fibrillation. J. Am. Coll. Cardiol. 51 (2007) 585-594
13. Mayr M., Liem D., Zhang J., Li X., Avliyakulov N.K., Yang J.I., et al. Proteomic and metabolomic analysis of cardioprotection: interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts. J. Mol. Cell. Cardiol. 46 (2009) 268-277
14. Cook S.A., Clerk A., and Sugden P.H. Are transgenic mice the 'alkahest' to understanding myocardial hypertrophy and failure?. J. Mol. Cell. Cardiol. 46 (2009) 118-129
15. Ingwall J.S. Transgenesis and cardiac energetics: new insights into cardiac metabolism. J. Mol. Cell. Cardiol. 37 (2004) 613-623
16. Neubauer S., Krahe T., Schindler R., Horn M., Hillenbrand H., Entzeroth C., et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86 (1992) 1810-1818
17. Schneider J.E., Stork L.A., Bell J.T., ten H.M., Isbrandt D., Clarke K., et al. Cardiac structure and function during ageing in energetically compromised guanidinoacetate N-methyltransferase (GAMT)-knockout mice-a one year longitudinal MRI study. J. Cardiovasc. Magn. Reson. 10 (2008) 9
18. Mayr M. Metabolomics: ready for the prime time?. Circ. Cardiovasc. Genet. 1 (2008) 58-65